Federated Hermes, Inc. Adaptive Biotechnologies Corp Transaction History

Federated Hermes, Inc.

  • $43.9 Billion
  • Q1 2025

A detailed history of Federated Hermes, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 3,058 shares of ADPT stock, worth $30,182. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,058
Previous 7,970 61.63%
Holding current value
$30,182
Previous $47,000 53.19%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025
SELL
$6.07 - $8.66 $29,815 - $42,537
-4,912 Reduced 61.63%
3,058 $22,000
Q4 2024

Feb 13, 2025
SELL
$4.37 - $6.78 $14,372 - $22,299
-3,289 Reduced 29.21%
7,970 $47,000
Q3 2024

Nov 13, 2024
SELL
$3.37 - $5.12 $155,063 - $235,586
-46,013 Reduced 80.34%
11,259 $57,000
Q2 2024

Aug 08, 2024
SELL
$2.34 - $3.96 $2.91 Million - $4.93 Million
-1,244,445 Reduced 95.6%
57,272 $207,000
Q1 2024

May 14, 2024
BUY
$2.88 - $4.8 $256,484 - $427,473
89,057 Added 7.34%
1,301,717 $4.18 Million
Q4 2023

Jan 31, 2024
SELL
$3.46 - $5.33 $597,012 - $919,675
-172,547 Reduced 12.46%
1,212,660 $5.94 Million
Q3 2023

Nov 13, 2023
BUY
$5.07 - $8.44 $1.38 Million - $2.3 Million
272,720 Added 24.51%
1,385,207 $7.55 Million
Q2 2023

Aug 14, 2023
SELL
$6.19 - $8.78 $393,492 - $558,135
-63,569 Reduced 5.41%
1,112,487 $7.46 Million
Q1 2023

May 08, 2023
SELL
$7.8 - $10.11 $1.8 Million - $2.34 Million
-231,130 Reduced 16.42%
1,176,056 $10.4 Million
Q4 2022

Feb 13, 2023
BUY
$6.26 - $9.34 $36,602 - $54,610
5,847 Added 0.42%
1,407,186 $10.8 Million
Q3 2022

Nov 14, 2022
BUY
$6.5 - $12.67 $24,739 - $48,222
3,806 Added 0.27%
1,401,339 $9.98 Million
Q2 2022

Aug 15, 2022
BUY
$6.4 - $14.73 $5.38 Million - $12.4 Million
841,334 Added 151.26%
1,397,533 $11.3 Million
Q1 2022

May 13, 2022
BUY
$10.12 - $28.9 $5.63 Million - $16.1 Million
556,199 New
556,199 $7.72 Million
Q2 2021

Aug 16, 2021
SELL
$32.22 - $44.59 $1.35 Million - $1.87 Million
-42,000 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$37.26 - $67.74 $673,958 - $1.23 Million
-18,088 Reduced 30.1%
42,000 $1.69 Million
Q4 2020

Feb 12, 2021
BUY
$45.01 - $65.47 $814,140 - $1.18 Million
18,088 Added 43.07%
60,088 $3.55 Million
Q2 2020

Aug 13, 2020
SELL
$24.95 - $48.38 $356,685 - $691,640
-14,296 Reduced 25.39%
42,000 $2.03 Million
Q1 2020

May 13, 2020
BUY
$16.96 - $34.16 $153,674 - $309,523
9,061 Added 19.18%
56,296 $1.56 Million
Q4 2019

Feb 14, 2020
BUY
$24.56 - $32.8 $128,571 - $171,707
5,235 Added 12.46%
47,235 $1.41 Million
Q3 2019

Nov 14, 2019
SELL
$30.31 - $53.51 $1 Million - $1.77 Million
-33,000 Reduced 44.0%
42,000 $1.3 Million
Q2 2019

Aug 14, 2019
BUY
$40.3 - $48.3 $3.02 Million - $3.62 Million
75,000 New
75,000 $3.62 Million

Others Institutions Holding ADPT

# of Institutions
246
Shares Held
156M
Call Options Held
44.3K
Put Options Held
47.8K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.41B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email